eLife (Feb 2016)

Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity

  • Prithvi Raj,
  • Ekta Rai,
  • Ran Song,
  • Shaheen Khan,
  • Benjamin E Wakeland,
  • Kasthuribai Viswanathan,
  • Carlos Arana,
  • Chaoying Liang,
  • Bo Zhang,
  • Igor Dozmorov,
  • Ferdicia Carr-Johnson,
  • Mitja Mitrovic,
  • Graham B Wiley,
  • Jennifer A Kelly,
  • Bernard R Lauwerys,
  • Nancy J Olsen,
  • Chris Cotsapas,
  • Christine K Garcia,
  • Carol A Wise,
  • John B Harley,
  • Swapan K Nath,
  • Judith A James,
  • Chaim O Jacob,
  • Betty P Tsao,
  • Chandrashekhar Pasare,
  • David R Karp,
  • Quan Zhen Li,
  • Patrick M Gaffney,
  • Edward K Wakeland

DOI
https://doi.org/10.7554/eLife.12089
Journal volume & issue
Vol. 5

Abstract

Read online

Targeted sequencing of sixteen SLE risk loci among 1349 Caucasian cases and controls produced a comprehensive dataset of the variations causing susceptibility to systemic lupus erythematosus (SLE). Two independent disease association signals in the HLA-D region identified two regulatory regions containing 3562 polymorphisms that modified thirty-seven transcription factor binding sites. These extensive functional variations are a new and potent facet of HLA polymorphism. Variations modifying the consensus binding motifs of IRF4 and CTCF in the XL9 regulatory complex modified the transcription of HLA-DRB1, HLA-DQA1 and HLA-DQB1 in a chromosome-specific manner, resulting in a 2.5-fold increase in the surface expression of HLA-DR and DQ molecules on dendritic cells with SLE risk genotypes, which increases to over 4-fold after stimulation. Similar analyses of fifteen other SLE risk loci identified 1206 functional variants tightly linked with disease-associated SNPs and demonstrated that common disease alleles contain multiple causal variants modulating multiple immune system genes.

Keywords